NETEASE, INC. Cost-method Investments, Other than Temporary Impairment
NETEASE, INC. (NTES) reported Cost-method Investments, Other than Temporary Impairment of CNY 58.54 million for the 12-month period ending 2017-12-31, per its 20-F filed 2018-04-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2018-04-20
CNY
| Period end | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|
| 2017-12-31 | 58.54M CNY 20-F · filed 2018-04-20 |
| 2016-12-31 | 278.91M CNY 20-F · filed 2018-04-20 |
| 2015-12-31 | 12.04M CNY 20-F · filed 2018-04-20 |
| 2014-12-31 | 24.04M CNY 20-F · filed 2017-04-21 |
USD
| Period end | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|
| 2017-12-31 | $9.00M 20-F · filed 2018-04-20 |
| 2016-12-31 | $40.17M 20-F · filed 2017-04-21 |
| 2015-12-31 | $1.86M 20-F · filed 2016-04-22 |
| 2014-12-31 | $3.88M 20-F · filed 2015-04-24 |